BioIVT Acquires Keystone Biologicals

BioIVT has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. The acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.
 
"With the addition of Keystone Biologicals, BioIVT broadens its product offerings and better supports clients in the in vitro diagnostic (IVD) market," said BioIVT Chief Executive Officer Jeffrey Gatz. "This acquisition furthers our mission of becoming the partner of choice for both biopharmaceutical and diagnostic clients."
 
"In BioIVT, we have found a like-minded partner whose desire to provide the highest quality research samples and customized products and services to satisfy client needs equals our own," said Keystone Biologicals President Darren Lowenthal. "We are delighted to be joining BioIVT and look forward to working together for the benefit of all our clients."

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com